Maohong Zhang
- Topics
- Bioactive Natural Diterpenoids Research (4 papers)Platelet Disorders and Treatments (3 papers)Cell death mechanisms and regulation (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Maohong Zhang
20 papers receiving 294 citations
Peers
Comparison fields: 5 of 59
- Hematology 152
- Molecular Biology 104
- Immunology 55
- Pathology and Forensic Medicine 51
- Genetics 29
Countries citing papers authored by Maohong Zhang
This map shows the geographic impact of Maohong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maohong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maohong Zhang more than expected).
Fields of papers citing papers by Maohong Zhang
This network shows the impact of papers produced by Maohong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maohong Zhang. The network helps show where Maohong Zhang may publish in the future.
Co-authorship network of co-authors of Maohong Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Maohong Zhang. A scholar is included among the top collaborators of Maohong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maohong Zhang. Maohong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial]. | 2 |
| 7 | [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia]. | 3 |
| 8 | 20 | |
| 9 | 23 | |
| 10 | [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors]. | 9 |
| 11 | 44 | |
| 12 | 13 | |
| 13 | [Study on the direct MAIPA technique in the differential diagnosis of immune and non-immune thrombocytopenia]. | 1 |
| 14 | 15 | |
| 15 | [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia]. | 3 |
| 16 | [A randomized controlled and multicenter clinical study of ferrous L-threonate in treatment of iron deficiency anemia]. | 2 |
| 17 | 23 | |
| 18 | 113 | |
| 19 | 10 | |
| 20 | 4 |
About Maohong Zhang
Maohong Zhang is a scholar working on Hematology, Business and International Management and Pharmacology, having authored 20 papers that have together received 305 indexed citations. Recurring topics across this work include Bioactive Natural Diterpenoids Research (4 papers), Platelet Disorders and Treatments (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Hematology (152 citations), Pathology and Forensic Medicine (51 citations) and Genetics (29 citations). Maohong Zhang has collaborated with scholars based in China and United States. Frequent co-authors include Jun Peng, Ming Hou, Xuebin Ji, Chunqing Zhang, Ping Qin, Xueyong Wang, Yan Shi, Qu Lin, Ming Hou and Xiangyuan Wu. Their work appears in journals such as Thrombosis Research, American Journal of Hematology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.